Items where Author is "Riley, CL"

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 3.

RILEY, C.L., MATHIEU, M.G., CLARK, R.E., MCARDLE, S.E. and REES, R.C., 2009. Tumour antigen-targeted immunotherapy for chronic myeloid leukaemia: is it still viable? Cancer Immunology Immunotherapy, 58 (9), pp. 1489-1499.

RILEY, C.L., 2008. Investigation of BCR/ABL class I/II epitopes to potentiate anti-tumour responses in vivo and in vitro for the potential immunotherapy of CML. PhD, Nottingham Trent University.

MATHIEU, M.G., KNIGHTS, A.J., PAWELEC, G., RILEY, C.L., WERNET, D., LEMONNIER, F.A., STRATEN, P.T., MUELLER, L., REES, R.C. and MCARDLE, S.E., 2007. HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides. Cancer Immunology Immunotherapy, 56 (12), pp. 1885-1895. ISSN 0340-7004

This list was generated on Wed Mar 29 17:05:42 2023 UTC.